Description

Dexilant (dexlansoprazole) Hard Capsules with Modified Release 30 mg. №14

Ingredients

Active ingredient: Dexlansoprazole 30 mg.
Other ingredients: Microcrystalline cellulose, sugar spheres, talc, methacrylic acid copolymer, and more.

Dosage

Recommended dosage: Take 1 capsule daily before a meal. Swallow the capsule whole with water. Do not crush or chew the capsule.

Indications

Indicated for: Treatment of gastroesophageal reflux disease (GERD), healing of erosive esophagitis, and maintenance of healed erosive esophagitis.

Contraindications

Do not use Dexilant if you:

• Are allergic to dexlansoprazole or any other ingredients in the product.
• Are taking rilpivirine-containing products.

Directions

Follow these directions: Take Dexilant exactly as prescribed by your healthcare provider. Do not exceed the recommended dosage or duration of treatment.

Scientific Evidence

Dexilant (dexlansoprazole) has shown significant efficacy in the treatment of GERD and erosive esophagitis. Studies have demonstrated its ability to provide long-lasting relief from symptoms and promote healing of the esophagus. Clinical trials have also highlighted the safety profile of Dexilant in comparison to other proton pump inhibitors.

Additional Information

Storage: Store Dexilant at room temperature away from moisture and heat. Keep the capsules in their original packaging.
Side effects: Common side effects may include diarrhea, stomach pain, and nausea. Contact your doctor if you experience severe or persistent side effects.

Pharmacologically, Dexilant works by inhibiting the proton pump in the stomach, reducing the production of stomach acid. This action helps in relieving symptoms of acid reflux and allows the esophagus to heal from any damage caused by excess acid exposure.

Comparative studies have shown that Dexilant, with its modified release formulation, provides superior acid suppression and symptom relief compared to other proton pump inhibitors. The extended-release feature of Dexilant ensures sustained efficacy over a 24-hour period, offering patients better control of their acid-related conditions.